SCHEMBL6597702

SCHEMBL6597702

COC(C)CNS(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CA1 P00915 4/20 0.47
CA2 P00918 4/20 0.47
ALDH1A1 P00352 3/20 0.47
GBA1 P04062 1/20 0.47
CYP19A1 P11511 1/20 0.46
TSHR P16473 1/20 0.46
MMP1 P03956 2/20 0.45
MMP2 P08253 2/20 0.45
MMP9 P14780 2/20 0.45
MMP13 P45452 2/20 0.45
MMP3 P08254 1/20 0.45
MMP7 P09237 1/20 0.45
NHERF1 O14745 1/20 0.45
MMP8 P22894 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31234593 0.84 CA1 (0.54) MEN1KMT2ACA1CA2ALDH1A1
SCHEMBL18680063 0.83 GBA1 (0.54) MEN1KMT2ACA1CA2ALDH1A1
SCHEMBL2934786 0.83 ALDH1A1 (0.67) GAASIGMAR1CA1CA2ALDH1A1
SCHEMBL31234771 0.80 CA2 (0.53) GAAMEN1KMT2ACA1CA2
SCHEMBL6598439 0.80 MEN1 (0.48) GAAMEN1KMT2ACA1CA2
SCHEMBL6324078 0.80 SIGMAR1 (0.51) GAASIGMAR1CA1CA2ALDH1A1
SCHEMBL3412102 0.80 CA1 (0.52) GAASIGMAR1CA1CA2ALDH1A1
SCHEMBL6321465 0.80 CA1 (0.52) GAASIGMAR1CA1CA2ALDH1A1
SCHEMBL3412348 0.80 CA1 (0.52) GAASIGMAR1CA1CA2ALDH1A1
SCHEMBL5273173 0.80 CYP19A1 (0.47) GAASIGMAR1CA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414801-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 AstraZeneca AB (SE) 2004-05-06 EP disclosed
WO-2003004472-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 ASTRAZENECA AB (SE) 2003-01-16 WO disclosed